A Post Authorization Registry Study of Participants Treated With LEQEMBI (clinicaltrials.gov) - Sep 23, 2026 - P=N/A | N=400 | Recruiting | Sponsor: Eisai Limited | Not yet recruiting ➔ Recruiting
Enrollment open • Alzheimer's Disease • CNS Disorders
|